Clinical Trials
5 trialsNCT07416695 2026-04-29
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
Shanghai Henlius Biotech
Phase 1 Recruiting
NCT06179069 2026-04-03
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Zai Lab (Hong Kong), Ltd.
Phase 1 Recruiting
NCT07110103 2026-02-27
JACKPOT38
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06021483 2025-09-16
Observational Study to Evaluate the Safety and Efficacy of Zepzelcaâ„¢ Injection
Boryung Pharmaceutical Co., Ltd
Recruiting
NCT06475209 2024-06-26
Adebrelimab + Apatinib in SCLC Maintenance Therapy
Tang-Du Hospital
Phase 2 Recruiting